Conn. fuels burst of stem cell research programs

Connecticut's decision to funnel $100 million into embryonic stem cell research has fueled a host of research programs in the state. Scientists at UConn, Yale and other research centers say that their work is fast gaining international recognition. The money is buying new scientific equipment that can't qualify for federal funds and attracting top stem cell researchers from around the country. New stem cell lines are being cultivated for research use. And it's all being done with remarkably little controversy. About the only real problem Connecticut has experienced: The panel picked to award grants was overwhelmed by the number of applications it received.

- read the report on Connecticut in The New York Times

Suggested Articles

Antibiotics dubbed odilorhabdins (ODLs), inspired by soil-dwelling nematodes, hold promise for treating antibiotic-resistant infections.

A PureTech startup is developing an immune-responsive hydrogel that releases a corticosteroid into arthritic joints based on their level of inflammation.

A trial of a retinal implant built from embryonic stem cells produced encouraging results in patients with dry age-related macular degeneration.